Loading…
Wednesday, January 22 • 4:25pm - 5:00pm
Track B: Dive Into Risk-Based Monitoring (RBM) As A Business Intelligence Of The Clinical Trials. Are We Realizing The Full Potential?

Sign up or log in to save this to your schedule and see who's attending!

  • Elevate monitoring to the next level through continuous improvement, organizational silos, reduction, and increased efficiency
  • Understand key risk indicators, thresholds, algorithms, and issue management
  • Envision RBM as a business intelligence function in the clinical trials oversight to expand its benefits

Speakers
avatar for Vera Pomerantseva

Vera Pomerantseva

Senior Central Monitoring Lead, Bristol-Myers Squibb
Over 18 years of pharmaceutical industry experience in various functions, such as analytics, clinical operations, project management, trainings and risk-based monitoring. Published author of multiple articles in international magazines, such as Pharmaceutical Medicine Journal of New... Read More →


Wednesday January 22, 2020 4:25pm - 5:00pm